Impact Fusion International Announced An Additional Debt Reduction of Its Long Term Debt by $684,629
NAPOLEONVILLE, LA / ACCESSWIRE / December 28, 2021 / Impact Fusion International, Inc. (OTC PINK:IFUS)The Company is pleased to announce...
Day: December 28, 2021
Rushnet, Inc Through Its Subsidiaries heliosDX and Grandeza Healthcare Achieve Major Financial Milestone
ALPHARETTA, GA / ACCESSWIRE / December 28, 2021 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce heliosDX...
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your SmartphoneNow Easy to Buy and Use: No Prescription...
American Family Care Smashes Franchise Development Records
Nation's Largest Provider of Urgent Care Capitalizes on Interest in Healthcare Industry InvestmentsBIRMINGHAM, AL / ACCESSWIRE / December 28, 2021...
PacBio’s New HiFiViral Surveillance Kit Performance is Not Impacted by Omicron Mutations, Delivering Complete SARS-CoV-2 Genomes for All Circulating Variants
HiFiViral Solution helps to accelerate understanding of the Omicron variant, providing information that is important to public health responseMENLO PARK,...
Milestone Scientific Announces Purchase of CompuFlo / CathCheck™ Verification System Disposables at Two Additional Premier Hospitals
Both hospitals belong to large hospital systems representing future growth opportunitiesROSELAND, N.J., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc....
BioVie to Participate at the LifeSci Partners 11th Annual Corporate Access Event
RENO, Nev., Dec. 28, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing...
Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being...
Baudax Bio Announces $4.2 Million Registered Direct Offering
MALVERN, Pa., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX) (the “Company”), a pharmaceutical company focused on commercializing...
Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference
DURHAM, N.C., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing,...
Kiniksa Announces Results from Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS
HAMILTON, Bermuda, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio...
Correction: Regarding results of a share buy-back offer
Joint stock company “Olainfarm”, hereinafter referred to as - “the Company”, hereby informs that on the 27th of December, 2021 joint...
Nexstim Receives an NBS System Upgrade Order from a Customer in the United States
Press release, Helsinki, 28 December 2021 at 10 AM (EET) Nexstim Receives an NBS System Upgrade Order from a Customer...
On substantial participation (4) – specified
On December 27th, 2021 JSC Olainfarm has received specified announcement on substantial participation from AS AB CITY. The received announcement...
Sosei Heptares to present at 40th Annual J.P. Morgan Healthcare Conference
TOKYO, Japan and LONDON, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Sosei Group Corporation (“the Company”; TSE: 4565), today announced its...
Nykode Therapeutics announces first subject dosed with its T cell focused next-generation SARS-CoV-2 vaccine candidate
First subject dosed with Nykode Therapeutics’ T cell focused SARS-CoV-2 vaccine candidate. This is part of the ongoing phase 1/2...
Burning Rock Announces Results of 2021 Annual General Meeting
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a...
Eledon Pharmaceuticals to Participate in January 2022 Investor Conferences
IRVINE, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company...
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
MINNEAPOLIS, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to...
Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong
Infant Bacterial Therapeutics AB today announces that the Patent Offices of Brazil and Hong Kong have approved a patent of...